Merrimack Announced FDA Approval For Pancreatic Cancer Drug
October 23, 2015 at 10:04 AM EDT
Merrimack received FDA approval for its pancreatic cancer drug, known as ONIVYDE. ONIVYDE treats patients with an advanced form of pancreatic cancer where patients had already failed gemcitabine based therapy -- a chemotherapy drug.